New Campaign Educates People on What to Do When a Lung Nodule Is Found
In honor of World Lung Cancer Day on Friday, August 1, the American Lung Association, in partnership with Olympus, is launching a new educational campaign about lung nodules.
Lowering Drug Prices in the US—Look Within, Not Abroad
On May 12, 2025, the Trump administration issued an executive order to lower prescription drug costs by mandating that the US pay no more than prices in peer countries.
Drug innovation should benefit patients. PBMs are preventing that from happening.
The U.S. prescription drug market produces some of the world’s most advanced pharmaceutical innovations.
Cancer Anxiety Impacts Family Members of Those Diagnosed With Cancer
A cancer diagnosis places an emotional burden on the loved ones of those diagnosed, according to the results of a survey released by the Ohio State University Comprehensive Cancer Center (OSUCCC) — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
Liver cancer cases are projected to double, but more than half could be preventable
Liver cancer is the sixth most common cancer in the world, with around 870,000 cases in 2022. That’s projected to increase to 1.52 million cases in 2050, the new report found, if no changes are made.
‘Strategic approach’ key to meeting unique needs of young adults with colorectal cancer
The surge in early-onset colorectal cancer has prompted urgent campaigns to educate the public and health care providers.
Researchers uncover why colorectal cancer rates are higher among Black Americans and what can be done to change that
Despite being one of the most preventable and treatable cancers, colorectal cancer continues to claim more lives in Black communities than in any other racial group in the United States.
Cancer is on the rise, but promising treatments are as well
Despite cancer diagnoses being on the rise, Dr. Dinesh Kapur, of Eastern Connecticut Hematology & Oncology, is optimistic about the future.
Who Decides if a Cancer Drug Is “Worth It”? Former FDA Reviewer Points to Missing Input
When Erika Newell’s breast cancer recurred, she found herself doing something that she had rarely done before her diagnosis: carefully tracking news about science and drug approvals.
Kennedy to oust care task force, WSJ reports; HHS says no decision yet
U.S. Health Secretary Robert F. Kennedy Jr. is planning to remove all the members of an advisory panel that determines what cancer screenings and other preventive health measures insurers must cover, the Wall Street Journal reported on Friday, citing people familiar with the matter.
